June 1, 2021 Moderna Announces Initiation of Rolling Submission of Biologics License Application (BLA) with U.S. FDA for the Moderna COVID-19 Vaccine CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun. 1, 2021-- Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering...
Moderna Announces Initiation of Rolling Submission of Biologics License Application (BLA) with U.S. FDA for the Moderna COVID-19 Vaccine
read more